Mylan plans to improve access and increase costs savings within the $20 billion antiretroviral marketplace, by launching 2 of its HIV combination treatments—Symfi Lo and Cimduo—at a significant discount...
Neurological complications are known to be major contributors to morbidity and mortality in patients with HIV. In a recent review, researchers investigated how HIV-associated neurological complications...
The authors of a recent study compared outcomes among patients with HIV and tuberculosis who were treated with daily and intermittent antituberculosis regimens.
Researchers compared the effects of heavy, medium, occasional cannabis use on systemic inflammation and immune activation that is often present in patients with human immunodeficiency virus who are treated...
A recent perspective in the New England Journal of Medicine encouraged more use of generic drugs to treat HIV patients could help states struggling to afford HIV treatments.
Researchers determined whether the use of individual antiretroviral medications, when used in combination regimens, effect cardiac structure and function in youth with perinatally acquired HIV.
Because Hispanics are disproportionally affected by the HIV epidemic and by infection‐related cancers, researchers compared whether incidence rates for HPV‐related cancers and survival differed between...
The CDC analyzed 2014-2016 data from IQVIA Real World Data — Longitudinal Prescriptions and found that prescription rates for PrEP differed depending on race, sex, and geography.
